bpc 157 ماهو BPC-157 – Research Peptide BPC-157 | Research Grade Peptide

An earlier 12-week Phase 2b trial with 300 obese patients produced more encouraging numbers: the 1 mg dose group lost an average of 2.8 kg compared to 0.8 kg for placebo, with small but consistent improvements in cholesterol profiles and a reduction in patients with impaired glucose tolerance

The compound has been the subject of extensive preclinical research, particularly in models studying tissue repair, angiogenesis, and gastrointestinal mucosal integrity

& Reinecker, H

Cart No products in the cart

For hematocrit and reticulocyte counts, recommendations are to repeat these tests daily from the 5th to 7th days of treatment and then frequently until the hematocrit returns to a normal range.[9][16][22] Both serum potassium concentrations and the platelet count need to be monitored carefully after parenteral administration of cyanocobalamin